Genmab A/S's total assets for Q4 2024 were kr45.81B, an increase of 15.51% from the previous quarter. GB:0MGB total liabilities were kr9.11B for the fiscal quarter, a 17.78% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.